Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis

被引:0
作者
Atas, Hatice [1 ]
Canpolat, Filiz [1 ]
Eskioglu, Fatma [1 ]
机构
[1] Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Dept Dermatol, Ankara, Turkey
关键词
Behcet's disease; Mean platelet volume; Thrombosis; Vascular; CORONARY-ARTERY-DISEASE; ROUTINE MEASUREMENT; DIABETES-MELLITUS; ISCHEMIC-STROKE; SIZE; ANTICOAGULANT; HETEROGENEITY; HEMOSTASIS; THERAPY; TIME;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with Behcet's disease (BD) are recognized with increased risk for venous and/or arterial thrombosis. Thrombotic tendency of BD is not known. Vascular injury, loss and dysfunction/hyperfunction of endothelial cells are believed to play a role in thrombosis development. Injury and inflammation due to vasculitis can cause platelet response with increase in mean platelet volume (MPV) and thrombosis in BD. In this study, we aimed to compare the levels of MPV between patients with BD and healthy controls, and also show its effect on thrombosis. Methods: One hundred patients with BD and 100 healthy controls were evaluated for MPV levels with clinical findings in age-gender matched case-control study. The variables of patients and controls were compared and correlated using chi-square, Mann-Whitney U and Spearman tests. Logistic regression analysis was used to determine independent predictors of vascular involvement and thrombosis. Results: Mean MPV was significantly higher in patients with BD than healthy controls (MPV; Patients: 9.2 +/- 0.9 [7.3-12.9] vs. Controls: 8.2 +/- 0.6 [6.8-10.6] fl; P < 0.0001). Platelets levels were lower than controls, but not significantly (236 +/- 52.3 [112-451] vs. 245 +/- 52.8 [141-467] x10(9)/L, P = 0.55). Negative correlation was found between platelet count and MPV in patients (r = -0.51, P = 0.01). Presence of erythema nodosum (EN) and MPV were determined as predictors for vascular involvement and thrombosis (EN: P < 0.0001, OR [95% CI] = 35.4 [6.3-178.2]; MPV: P < 0.0001, OR [95% CI] = 12.8 [4.1-24.3]). Conclusion: MPV is a simple measurement for indirect monitoring of platelet activity and thrombotic potential. MPV and EN may be independent risk factors for vascular thrombosis in BD. Patients with higher MPV levels and EN in BD, might have been pursued closely for enhancing thrombosis. We advise to check the MPV and put the patients on anticoagulation if it is high. Keywords: Behcet's disease, Mean platelet volume, Thrombosis, Vascular
引用
收藏
页码:234 / 239
页数:6
相关论文
共 40 条
  • [11] Cush J., 2016, NEW EULAR GUIDELINES
  • [12] The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
    Davatchi, F.
    Assaad-Khalil, S.
    Calamia, K. T.
    Crook, J. E.
    Sadeghi-Abdollahi, B.
    Schirmer, M.
    Tzellos, T.
    Zouboulis, C. C.
    Akhlagi, M.
    Al-Dalaan, A.
    Alekberova, Z. S.
    Ali, A. A.
    Altenburg, A.
    Arromdee, E.
    Baltaci, M.
    Bastos, M.
    Benamour, S.
    Ben Ghorbel, I.
    Boyvat, A.
    Carvalho, L.
    Chen, W.
    Ben-Chetrit, E.
    Chams-Davatchi, C.
    Correia, J. A.
    Crespo, J.
    Dias, C.
    Dong, Y.
    Paixao-Duarte, F.
    Elmuntaser, K.
    Elonakov, A. V.
    Grana Gil, J.
    Haghdoost, A-A.
    Hayani, R. M.
    Houman, H.
    Isayeva, A. R.
    Jamshidi, A. R.
    Kaklamanis, P.
    Kumar, A.
    Kyrgidis, A.
    Madanat, W.
    Nadji, A.
    Namba, K.
    Ohno, S.
    Olivieri, I.
    Vaz Patto, J.
    Pipitone, N.
    de Queiroz, M. V.
    Ramos, F.
    Resende, C.
    Rosa, C. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (03) : 338 - 347
  • [13] Treatment strategies for Behcet's disease
    Fresko, Izzet
    Yazici, Hasan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (18) : 3211 - 3219
  • [14] PLATELET GLYCOPROTEIN IIB-IIIA AND SIZE ARE INCREASED IN ACUTE MYOCARDIAL-INFARCTION
    GILES, H
    SMITH, REA
    MARTIN, JF
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (01) : 69 - 72
  • [15] EULAR recommendations for the management of Behcet disease
    Hatemi, G.
    Silman, A.
    Bang, D.
    Bodaghi, B.
    Chamberlain, A. M.
    Gul, A.
    Houman, M. H.
    Kotter, I.
    Olivieri, I.
    Salvarani, C.
    Sfikakis, P. P.
    Siva, A.
    Stanford, M. R.
    Stuebiger, N.
    Yurdakul, S.
    Yazici, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) : 1656 - 1662
  • [16] Haznedaroglu IC, 1998, ACTA HAEMATOL-BASEL, V99, P236
  • [17] JAKUBOWSKI JA, 1985, J LAB CLIN MED, V105, P271
  • [18] ARACHIDONIC-ACID METABOLISM BY PLATELETS OF DIFFERING SIZE
    JAKUBOWSKI, JA
    THOMPSON, CB
    VAILLANCOURT, R
    VALERI, CR
    DEYKIN, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1983, 53 (03) : 503 - 511
  • [19] Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides
    Jennette, J. Charles
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (05) : 603 - 606